Current Opinion in Immunology Journal Citation Rate 2026

ISSN 0952-7915 eISSN 1879-0372 Elsevier BV GB

Q2 Quartile Established Impact

About Current Opinion in Immunology
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Current Opinion in Immunology (COI) is a peer-reviewed academic journal covering Immune Cell Function and Interaction and Immune Response and Inflammation, published by Elsevier BV in GB, catalogued under ISSN 0952-7915 (e-ISSN 1879-0372). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.98 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4120 USD).

Current Opinion in Immunology Citation Rate 2026 — In Context

Current Opinion in Immunology has a 2025 2-Year Citation Rate (OpenAlex) of 2.98, placing it in the Q2 quartile within the Immune Cell Function and Interaction research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Current Opinion in Immunology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Current Opinion in Immunology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Current Opinion in Immunology against similar journals in the field, use our journal comparison tool.

Submission Tips for Current Opinion in Immunology
  • Budget $4120 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Immune Cell Function and Interaction, Immune Response and Inflammation, Immunotherapy and Immune Responses. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Current Opinion in … Compares
Citation Rate vs Field Avg
-23%
Field avg: 3.85
APC vs Field Avg
-1%
Field avg: $4175

Compared against 25 journals in the same research areas.

ISSN (Print) 0952-7915
ISSN (Online) 1879-0372
Publisher Elsevier BV
Country United Kingdom
APC / Cost $4120 USD
In-depth profile & metrics

Current Opinion in Immunology is published by Elsevier BV and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4120.

In our subject taxonomy, Current Opinion in Immunology is classified under Immune Cell Function and Interaction, Immune Response and Inflammation, Immunotherapy and Immune Responses and Monoclonal and Polyclonal Antibodies Research.

Current Opinion in Immunology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.982.

Research Areas
Links
Frequently Asked Questions about Current Opinion in Immunology

Current Opinion in Immunology does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.982 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Current Opinion in Immunology is not an open access journal.

The Article Processing Charge (APC) for Current Opinion in Immunology is $4120 USD.

Current Opinion in Immunology is published by Elsevier BV.

Current Opinion in Immunology shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Current Opinion in Immunology is 0952-7915. Its electronic ISSN (eISSN) is 1879-0372.

Current Opinion in Immunology sits in the Q2 quartile based on its latest impact factor of 2.98, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.982
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.982 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S170047187

Get weekly updates for Immune Cell Function and Interaction journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google